Related Experiment Video
Updated: May 18, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Delayed versus immediate stenting for the treatment of ST-elevation acute myocardial infarction with a high thrombus
Dan Ke1, Wenliang Zhong, Lin Fan
1Department of Cardiology, Fujian Provincial Corps Hospital, Chinese People's Armed Police Forces, Fuzhou, People's Republic of China.
Insights
For ST-elevation myocardial infarction (STEMI) patients with high thrombus burden (HTB), delayed stenting after initial thrombectomy is safe and effective. This approach may improve myocardial perfusion, left ventricular function recovery, and reduce major adverse cardiac events at one year.
Area of Science:
- Cardiology
- Interventional Cardiology
- Acute Coronary Syndromes
Background:
- High thrombus burden (HTB) is a significant predictor of suboptimal outcomes in primary percutaneous coronary intervention for ST-elevation myocardial infarction (STEMI).
- Optimal timing for stent implantation in STEMI patients with HTB remains a subject of investigation.
Purpose of the Study:
- To compare the clinical outcomes of immediate stenting versus delayed stenting in STEMI patients with high thrombus burden (HTB).
Main Methods:
- A retrospective, nonrandomized study of 103 STEMI patients with HTB (thrombus burden score ≥3).
- Patients were assigned to either immediate stenting (IS group, n=50) or delayed stenting (DS group, n=53) with enhanced antithrombotic therapy, with stenting deferred for at least 7 days.
- Angiographic assessment included Thrombolysis in Myocardial Infarction (TIMI) flow score and myocardial blush grade (MBG). Left ventricular ejection fraction (LVEF) and major adverse cardiac events (MACE) were evaluated.
Main Results:
- The delayed stenting group demonstrated improved immediate MBG (P<0.001), higher LVEF at 6 months (P=0.044), and a lower MACE rate at 1 year (log-rank P=0.008).
- Immediate stenting and high thrombus burden score were independent predictors of poor myocardial perfusion.
- Delayed stenting was particularly beneficial for male patients, younger patients, and those with larger infarct-related arteries, higher thrombus burden scores, or lower TIMI flow scores, potentially avoiding stent implantation in 22.6% of cases.
Conclusions:
- Delayed stenting is a safe and feasible strategy for STEMI patients with HTB following initial thrombectomy.
- This approach may lead to better immediate myocardial perfusion, enhanced left ventricular function recovery, and a reduced incidence of MACE at one-year follow-up.
Objectives:
High thrombus burden (HTB) is an independent predictor of no flow or low reflow during a primary percutaneous coronary intervention. This study aimed to compare immediate versus delayed stenting in ST-elevation myocardial infarction (STEMI) patients with HTB.
Methods:
In this retrospective, nonrandomized study, a total of 103 consecutive STEMI patients with HTB (thrombus burden score, TBS≥3) were assigned to immediate stenting (IS group, n=50) or delayed stenting (DS group, n=53), a decision that was made at the discretion of the operators. The IS group received stent placement immediately, whereas the DS group was given enhanced antithrombotic therapies and deferred for stenting at least 7 days later. Thrombolysis in myocardial infarction (TIMI) flow score (TIMIs) and myocardial blush grade (MBG) were assessed angiographically and the left ventricular ejection fraction (LVEF) was measured echocardiographically. The major adverse cardiac event (MACE) was the composite of cardiac death, reinfarction, target vessel revascularization, heart failure, and major bleeding.
Results:
The DS group had better immediate MBG (P<0.001), higher LVEF at 6 months (P=0.044), and lower MACE rate at 1 year (log-rank P=0.008). Multiple logistic regression identified immediate stenting (odds ratio 7.4, 95% confidence interval 2.1-26.6; P=0.002) and high TBS (odds ratio 2.6, 95% confidence interval 1.1-6.5, P=0.034) as the independent predictors of poor myocardial perfusion. Delayed stenting benefited the male patients, those who were of a younger age, and those who had a larger infarction-related artery, higher TBS, or lower TIMIs in terms of MBG or MACE. Delayed stenting avoided stent implantation of the infarct-related artery in 12/53 (22.6%) patients particularly in the younger patients.
Conclusion:
For STEMI patients with HTB who have undergone initial thrombectomy, delayed stenting is safe and feasible, and may be associated with better immediate myocardial perfusion, more LV function recovery, and less occurrence of MACE at the 1-year follow-up.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

